Serous Cystadenocarcinoma
Watchlist
Retrieved
2021-01-18
Source
Trials
—
Genes
TP53,
BRCA1,
ERBB2,
BRCA2,
ESR1,
H3P10,
MAGEA1,
CTNNB1,
NEURL1,
PAX8,
CDKN2A,
NEU1,
VEGFA,
PGR,
HNF1B,
PTEN,
DDIT4,
PTGS2,
MAGED4,
MAGED4B,
FBXW7,
SCO2,
LIMS3,
ARAP1,
PDCD5,
MBD2,
PROM1,
TICAM2,
C17orf97,
LIMS4
TP53,
BRCA1,
ERBB2,
BRCA2,
ESR1,
H3P10,
MAGEA1,
CTNNB1,
NEURL1,
PAX8,
CDKN2A,
NEU1,
VEGFA,
PGR,
HNF1B,
PTEN,
DDIT4,
PTGS2,
MAGED4,
MAGED4B,
FBXW7,
SCO2,
LIMS3,
ARAP1,
PDCD5,
MBD2,
PROM1,
TICAM2,
C17orf97,
LIMS4,
TUBB3,
TMED7-TICAM2,
TNXB,
LOC110806263,
SYP,
SPP1,
SPARC,
H3P23,
SRA1,
ZNRD2,
LIMS2,
DCTN6,
KRT20,
HDAC7,
WT1-AS,
TMED7,
SOX7,
CD274,
PDCD4,
LPAR3,
PSD4,
SHBG,
SIRT1,
GALNT6,
SLC22A16,
MUC16,
RASSF1,
UBE2C,
CCR9,
PRAME,
ABCA4,
CCL25,
TYMP,
DAB2,
CLDN3,
CLDN4,
CEACAM7,
CEACAM3,
CEACAM5,
CDK2,
CALB2,
SLC25A20,
CA2,
BRAF,
BCL2,
ASNS,
ARNTL,
AR,
AQP5,
AQP1,
APOA1,
AMH,
ALK,
AKT1,
DHCR24,
EGF,
PSMD9,
EGFR,
PSG2,
AHR,
PPP2R1A,
POLH,
P2RX5,
NME1,
NCAM1,
MLH1,
MGMT,
MAGEA3,
KRAS,
CD82,
IGF2,
IFI27,
HDAC1,
GPX3,
GATA6,
NR5A2,
FLNA,
EPHB3,
EPHA1,
MAP2K7
Drugs
—
Registered!
Serous cystadenocarcinoma is a type of tumor in the cystadenocarcinoma grouping.
Most commonly, the primary site of serous cystadenocarcinoma is the ovary. Rare occurrence in the pancreas has been reported, although this is not typical, with the majority of microcystic pancreatic masses representing alternate disease processes such as the more benign serous cystadenoma.